Clinical Trials in Bulgaria

• A study to find how well budoprutug (TNT119) works and how safe it is in participants with Systemic Lupus Erythematosus Recruiting
  2024-520385-57-01 Phase I (Other) Systemic Lupus Erythematosus Climb Bio Inc.
• A 6-Week, Multicenter, Open-Label, Monotherapy, Extension Study of SPT-300 in Adults with Major Depressive Disorder, With or Without Anxious… Recruiting
  2025-522347-18-00 Phase II Major Depressive Disorder (MDD), with or without Anxious Dis… Seaport Therapeutics Inc.
• A study to test whether treatment with BI 770371 in combination with pembrolizumab with or without cetuximab helps people with head and neck… Recruiting
  2024-517091-38-00 Phase I (Other) Head and neck squamous cell carcinoma Boehringer Ingelheim International GmbH
• A Phase 2b Study to Assess the Efficacy and Safety of IMVT-1402 in Patients With Graves' Disease Recruiting
  2025-521920-31-00 Phase II Graves’ Disease Immunovant Sciences GmbH
• A Study of BMS-986504 in Combination with Pembrolizumab Plus Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line M… Recruiting
  2025-521511-40-00 Phase II/III metastatic non-small cell lung cancer Bristol-Myers Squibb Services Unlimited Company
• A study to assess the efficacy and safety of ITI-1284 as adjunctive treatment in patients with Generalized Anxiety Disorder Recruiting
  2024-513302-56-00 Phase II Generalized Anxiety Disorder Intra-Cellular Therapies Inc.
• A Study to Evaluate the Efficacy and Safety of Mezagitamab Subcutaneous Injection Compared With Placebo in Adults With Chronic Immune Thromb… Recruiting
  2024-514401-54-00 Phase III Chronic Primary Immune Thrombocytopenia Takeda Development Center Americas Inc.
• A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) ( PREVAIL ) Recruiting
  2024-519345-30-00 Phase III IgA nephropathy Biogen Idec Research Limited
• A Study to Learn About the Study Medicine Called PF-07248144 in Combination with Fulvestrant in People with HR-positive, HER2-negative Advan… Recruiting
  2025-520566-22-00 Phase III Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic… Pfizer Inc.
• REGN7508 versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults. Recruiting
  2025-520478-20-00 Phase III Thromboembolic disease Regeneron Pharmaceuticals Inc.
• A Phase 3 Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder Recruiting
  2024-520165-32-00 Phase III BP-I mania or mania with mixed features Bristol-Myers Squibb Services Unlimited Company
• Study to Evaluate Plozasiran in Adults with Severe Hypertriglyceridemia at high risk of Acute Pancreatitis (SHASTA-5 Study) Recruiting
  2024-518206-40-00 Phase III Severe hypertriglyceridemia (SHTG) Arrowhead Pharmaceuticals Inc.
• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated with Alzheimer’s Disease. Recruiting
  2025-520613-31-00 Phase III Agitation Associated with Alzheimer’s Disease Bristol-Myers Squibb Services Unlimited Company
• A Phase 2 Study of the Effects and Safety of PF-07328948 in Adults with Heart Failure (BRANCH-HF) Recruiting
  2024-518438-94-00 Phase II Heart failure Pfizer Inc.
• Study to assess the efficacy and safety of adjunctive NBI-1065845 in adults with Major Depressive Disorder (MDD) Recruiting
  2024-519420-25-00 Phase III Major Depressive Disorder Neurocrine Biosciences Inc.
• Study to assess the maintenance of effect of NBI-1065845 as an adjunctive treatment in participants with Major Depressive Disorder (MDD) Recruiting
  2025-520541-72-00 Phase III Major Depressive Disorder Neurocrine Biosciences Inc.
• A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with moderate to severe hid… Recruiting
  2025-520564-17-00 Phase III Hidradenitis suppurativa (HS) MoonLake Immunotherapeutics AG
• EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting
  2025-521188-11-00 Phase III Type 2 diabetes Boehringer Ingelheim Espana S.A.; Boehringer Ingelheim International GmbH
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and … Recruiting
  2024-516652-18-00 Phase III Atherosclerotic cardiovascular disease (ASCVD) and obesity o… Amgen Inc.
• Study of Ruxolitinib Cream in Participants with Hidradenitis Suppurativa (TRuE-HS1) Recruiting
  2024-517632-22-00 Phase III Hidradenitis Suppurativa Incyte Corp.
• Clinical Randomised Phase 2 Trial of AP31969 versus Placebo for Rhythm Control of Atrial Fibrillation. Recruiting
  2025-521377-14-00 Phase II Atrial fibrillation Acesion Pharma ApS
• A randomized, phase 3 multicenter study to confirm the clinical efficacy of linaprazan glurate compared to lansoprazole in participants with… Recruiting
  2024-518714-31-00 Phase III Erosive esophagitis (EE) due to gastroesophageal reflux dise… Cinclus Pharma Holding AB (publ)
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-to-Severe Asthma Recruiting
  2024-517866-40-00 Phase II Moderate-to-severe Asthma Pfizer Inc.
• A study to investigate the effect of AZD6793 in participants with moderate to very severe chronic obstructive pulmonary disease Recruiting
  2025-520473-40-00 Phase II Moderate to Very Severe Chronic Obstructive Pulmonary Diseas… AstraZeneca AB

Showing 217–240 of 852 trials